Clinical trial Recruiting at 32 sites Observational Ages 12 and up

Tracking suicide attempts and suicidal thoughts in Flanders

Official title: The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders

Run by University Hospital, Ghent · NCT07021404 · Data updated 2026-11-12

This project collects detailed information about people in Flanders who have suicidal thoughts or who have survived suicide attempts to see how often these events happen, which methods are used, and whether they get follow-up care.

Quick facts

Study typeObservational
Ages12 Years and up
SexAll
Enrollment50000 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations33 sites (Aalst and 32 other locations)
StatusRecruiting
StartedDecember 31, 2006
Main results expectedMarch 31, 2033
Study endsMarch 31, 2033
Registry record updatedJune 15, 2025
Trial IDNCT07021404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are people who present alive to participating healthcare services in Flanders after a suicide attempt or with current suicidal thoughts.

Probably not a fit

People with accidental overdoses or intoxication without suicidal intent, individuals who died before arrival, and those treated outside the participating hospitals or region are not eligible and will not benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project registers the frequency and characteristics of suicidal ideation and suicide attempts among individuals presenting to emergency departments, psychiatric hospitals, mobile crisis teams, and general practitioners at participating centers in Flanders. Clinical staff conduct a semi-structured interview using the Guideline for Suicide Care and Evaluation (LOES) to record sociodemographic details, mental state, history of self-harm, method of attempt, and immediate care needs. The LOES basic assessment is done shortly after presentation to document cognition, observable behavior, psychiatric concerns, social support, hopelessness, and willingness to engage in follow-up. Data are compiled to map suicidal behaviors regionally and to identify gaps in aftercare and prevention pathways across sites.

Why it matters

Potential benefit: If successful, findings could help improve how emergency and mental health services identify people at risk and provide timely follow-up care in Flanders.

How similar studies have gone: Similar regional surveillance and registry efforts have previously provided valuable information for prevention and care planning, so the approach is established rather than novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Everyone who is admitted alive to the emergency department after a suicide attempt is included. All methods used during the suicide attempt are included. Regarding the method of suicide attempts, a distinction is made between self-injury (hanging, strangulation, drowning, stab and cut wounds, jumping from a height, etc.) and self-poisoning (ingestion of (psycho)pharmaceuticals, drugs, alcohol, chemicals, or other harmful substances).
* Everyone who is admitted with suicidal thoughts

Exclusion Criteria:

* Accidental overdose, e.g., someone taking medication for a medical condition without any intent to harm themselves
* Alcohol intoxication without any intent to harm oneself
* Accidental overdose involving party drugs
* Individuals who were deceased upon arrival at the hospital due to suicide

Where it's running

  • Azorg
    Aalst, Belgium
    Recruiting
  • Ziekenhuis aan de Stroom (UKJA)
    Antwerp, Belgium
    Recruiting
  • Universitair ziekenhuis Antwerpen
    Antwerp, Belgium
    Recruiting
  • Psychiatrisch ziekenhuis Bilzen-Hoeselt
    Bilzen, Belgium
    Recruiting
  • Imeldaziekenhuis
    Bonheiden, Belgium
    Recruiting
  • AZ Klina
    Brasschaat, Belgium
    Recruiting
Show 27 more locations
  • AZ sint Jan
    Bruges, Belgium
    Recruiting
  • AZ sint Lucas
    Bruges, Belgium
    Recruiting
  • AZ Sint Vincentius
    Deinze, Belgium
    Recruiting
  • AZ Sint Blasius
    Dendermonde, Belgium
    Recruiting
  • AZ Monica
    Deurne, Belgium
    Recruiting
  • AZ Diest
    Diest, Belgium
    Recruiting
  • AZ Alma
    Eeklo, Belgium
    Recruiting
  • Ziekenhuis Geel
    Geel, Belgium
    Recruiting
  • Ziekenhuis Oost Limburg
    Genk, Belgium
    Recruiting
  • AZ Jan Palfijn
    Ghent, Belgium
    Recruiting
  • AZ Sint-Lucas
    Ghent, Belgium
    Recruiting
  • AZ Sint Maria
    Halle, Belgium
    Recruiting
  • AZ Herentals
    Herentals, Belgium
    Recruiting
  • Jan Yperman ziekenhuis
    Ieper, Belgium
    Recruiting
  • Sint-Jozefskliniek
    Izegem, Belgium
    Recruiting
  • AZ Groeninge
    Kortrijk, Belgium
    Recruiting
  • Heilig Hart Lier
    Lier, Belgium
    Recruiting
  • AZ Voorkempen
    Malle, Belgium
    Recruiting
  • AZ Sint Maarten
    Mechelen, Belgium
    Recruiting
  • AZ oostende
    Ostend, Belgium
    Recruiting
  • AZ Oudenaarde
    Oudenaarde, Belgium
    Recruiting
  • AZ Delta
    Roeselare, Belgium
    Recruiting
  • Sint-Trudo ziekenhuis
    Sint-Truiden, Belgium
    Recruiting
  • Sint Andriesziekenhuis
    Tielt, Belgium
    Recruiting
  • AZ West
    Veurne, Belgium
    Recruiting
  • O.L.V. van Lourdes ziekenhuis Waregem
    Waregem, Belgium
    Recruiting
  • Vitaz
    Sint-Niklaas, Belgium
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.